OTCMKTS:BSEM BioStem Technologies (BSEM) Stock Price, News & Analysis → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free BSEM Stock Alerts 8.41 +0.80 (+10.51%) (As of 05/29/2024 09:04 PM ET) Add Compare Share Share Today's Range7.65▼8.9850-Day Range7.40▼15.5052-Week Range1.20▼15.50Volume15,400 shsAverage Volume28,645 shsMarket Capitalization$137.00 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get BioStem Technologies alerts: Email Address Ad Porter & CompanyObama’s Forever Term [exposed]Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here About BioStem TechnologiesBioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.Read More BSEM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BSEM Stock News HeadlinesMay 29 at 11:00 AM | globenewswire.comBioStem Technologies to Sponsor MRO Better Half DashMay 15, 2024 | finance.yahoo.comBSEM Again Bests Estimates as Growth AcceleratesMay 15, 2024 | finance.yahoo.comBioStem Technologies Inc (BSEM) Q1 2024 Earnings Call Transcript Highlights: A Remarkable ...May 14, 2024 | globenewswire.comBioStem Technologies Reports Record First Quarter Revenue of $41.9 MillionApril 30, 2024 | globenewswire.comBioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain AllograftsApril 24, 2024 | globenewswire.comBioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior ExchangeApril 2, 2024 | finance.yahoo.comQ4 2023 Biostem Technologies Inc Earnings CallApril 2, 2024 | finance.yahoo.comBSEM Continues to Post Stellar ResultsApril 1, 2024 | globenewswire.comBioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY IncreaseMarch 21, 2024 | globenewswire.comBioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024March 9, 2024 | seekingalpha.comBSEM BioStem Technologies, Inc.March 9, 2024 | finance.yahoo.comBioStem Technologies, Inc. (BSEM)March 1, 2024 | morningstar.comBioStem Technologies Inc BSEMFebruary 6, 2024 | finance.yahoo.comBSEM: BioStem Expands and ImprovesFebruary 6, 2024 | finance.yahoo.comBSEM Provides Good Value for Great ScienceFebruary 6, 2024 | finance.yahoo.comBSEM Worth a Look on Surging RevenuesFebruary 6, 2024 | finance.yahoo.comBSEM Sees Increasing DemandFebruary 6, 2024 | finance.yahoo.comBSEM Crushes Estimates on Stellar GrowthFebruary 6, 2024 | finance.yahoo.comBSEM: Investors Need to Pay Attention to BSEMSee More Headlines Receive BSEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioStem Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today5/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:BSEM Previous Symbol: CUSIPN/A CIK1658678 Webwww.biostemtechnologies.com Phone954-380-8342FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$16.68 million Price / Sales8.21 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares16,290,000Free FloatN/AMarket Cap$137.00 million OptionableN/A Beta0.15 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Jason V. MatuszewskiCEO, President, Director & SecretaryMr. Michael A. Fortunato CPAChief Financial OfficerMr. Andrew VanvurstCOO & DirectorDr. David M. WoynarowskiChief Medical OfficerMr. Larry JonesChief Revenue OfficerDr. Irmgard Huber M.D.International Medical Advisor & Interim Chief Medical OfficerMr. Shawn F. McCarrey (Age 66)Chief Commercial Officer More ExecutivesKey CompetitorsCorbus PharmaceuticalsNASDAQ:CRBPAlectorNASDAQ:ALECOculisNASDAQ:OCSKalVista PharmaceuticalsNASDAQ:KALVAbsciNASDAQ:ABSIView All Competitors BSEM Stock Analysis - Frequently Asked Questions How have BSEM shares performed in 2024? BioStem Technologies' stock was trading at 7.35 at the beginning of 2024. Since then, BSEM shares have increased by 14.4% and is now trading at 8.41. View the best growth stocks for 2024 here. Are investors shorting BioStem Technologies? BioStem Technologies saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 29,300 shares, an increase of 31.4% from the April 30th total of 22,300 shares. Based on an average daily volume of 66,400 shares, the short-interest ratio is currently 0.4 days. View BioStem Technologies' Short Interest. How were BioStem Technologies' earnings last quarter? BioStem Technologies, Inc. (OTCMKTS:BSEM) announced its earnings results on Tuesday, May, 14th. The company reported $0.20 EPS for the quarter, missing analysts' consensus estimates of $0.74 by $0.54. The business had revenue of $41.90 million for the quarter, compared to the consensus estimate of $12.70 million. How do I buy shares of BioStem Technologies? Shares of BSEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BSEM) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeWrite this ticker symbol down…StocksToTradeWho are Nvidia’s New Silent Partners?Weiss RatingsThe 7th Trillion Dollar Company?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.